Molloy Eleanor J, Di Fiore Juliann M, Martin Richard J
Division of Neonatology, Department of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA.
Biol Neonate. 2005;87(4):254-61. doi: 10.1159/000083958. Epub 2005 Feb 11.
Gastroesophageal reflux (GER) and apnea are both common occurrences in premature infants but their relationship is controversial. We present the evidence for and against an association between GER and apnea and discuss the merits and limitations of the various methodologies employed in characterizing such a relationship. Overall, GER and apnea do not appear temporally related in preterm infants, despite strong physiologic evidence that stimulation of laryngeal afferents elicits central apnea and laryngeal adduction. In a subpopulation of infants with neurodevelopmental compromise, there may be an increased incidence of both apnea and GER, although the direct association between GER and apnea in this population is unclear. Therefore, we believe there is no evidence to support widespread use of anti-reflux medications in the treatment of apnea in preterm infants. Further studies are needed to clarify the existence of a small subpopulation of infants who may have GER-induced apnea, to identify potential triggering mechanisms, and to document benefit from newer pharmacological approaches.
胃食管反流(GER)和呼吸暂停在早产儿中都很常见,但它们之间的关系存在争议。我们展示了支持和反对GER与呼吸暂停之间存在关联的证据,并讨论了用于描述这种关系的各种方法的优点和局限性。总体而言,尽管有强有力的生理学证据表明刺激喉传入神经会引发中枢性呼吸暂停和喉内收,但在早产儿中,GER和呼吸暂停在时间上似乎并无关联。在患有神经发育受损的婴儿亚组中,呼吸暂停和GER的发生率可能会增加,尽管该人群中GER与呼吸暂停之间的直接关联尚不清楚。因此,我们认为没有证据支持在治疗早产儿呼吸暂停时广泛使用抗反流药物。需要进一步研究以阐明可能存在GER诱发呼吸暂停的一小部分婴儿亚组的情况,确定潜在的触发机制,并记录从更新的药理学方法中获得的益处。